🦊/Investors

New Enterprise Associates (NEA)

Venture capitalActively deploying

Menlo Park · Seed–Late Stage · 72 people tracked

Also known as NEA · Nea Management Company, Llc · New Enterprise Associates

Find your way into New Enterprise Associates (NEA)

904 people in our graph share verified history with the New Enterprise Associates (NEA) team — schools, employers, funds. One of them is your warm intro.

Mike Volpiunlockedknows Scott Sandell · together at Stanford University Graduate School of Business (overlapped)
×2knows the team · via New Enterprise Associates (NEA)
×2knows the team · via Y Combinator
knows the team · via Stanford University Graduate School of Business
×3knows the team · via Robinhood
knows the team · via Science Logic
Fox Verdict
Sign up to see your fit

Investment thesis

NEA views venture investment as an enduring commitment to the people executing on innovative ideas rather than a transactional financial engagement. The firm partners with founders to support the realization of transformative concepts.

Source: firm website, verified Sep 22, 2026.

Stage
Seed–Late Stage
Check
$200K – $40M
HQ
Menlo Park, CA, US
Leads rounds
Leads
Instruments
Equity
Founded
1978
Last 12 months
57 investments
AUM
$35.6B
Tracked investments
1115
Unicorns
43
IPOs
65
Acquisitions
74

Team · 72 people

from the firm's website & curated & public directories
Liza K. Landsman Gold· General Partner
Ayush Goradia· Principalin
Hunter Worland· Principalin
James Kaplan· Principalin
Lulu Xu· Principal
Mike O'Dell· Venture Partner
Alexa Grabelle· Associatein
Claudia Fan Munce· Venture Advisor
Madison Faulkner· Venture Advisor
Perry Wallack· Associatein
Ryan Psik· Associatein
Thomas Joshi· Associate

20 people who came through New Enterprise Associates (NEA) went on to found or lead other companies.

+ 9 more

What they invest in

from 731 of 1115 portfolio companies

AI & Machine Learning ×260SaaS ×195Enterprise Software ×189Healthtech ×184Biotech ×149Cloud Computing ×76Data & Infrastructure ×75Developer Tools ×75

HQs:United States×532China×10United Kingdom×10India×10Canada×7Germany×6

Who they back

founder profiles across 392 portfolio companies
43%
solo founders
168 of 392 mapped founding teams
46%
repeat founders
of 496 founders with career history
~3 yrs
old at investment
median across 182 dated deals

Founding team size:solo founder×1682 founders×1313 founders×584+ founders×35

Where their founders studiedfrom 466 founders with education data

Stanford University ×40University of California, Berkeley ×31Massachusetts Institute of Technology ×22Stanford University Graduate School of Business ×18Cornell ×14Harvard Business School ×14Duke University ×12University of Cambridge ×12

What their founders studiedfrom 428 founders with field-of-study data

Computer Science ×162Engineering ×105Business & Management ×56Economics ×37Finance & Accounting ×27Mathematics & Statistics ×26Life Sciences ×22Physics ×21

Where their founders worked beforefrom 496 founders with career history

Stanford University ×24Facebook ×14Google ×8McKinsey & Company ×8Goldman Sachs ×7Carnegie Mellon University ×6IBM ×6Massachusetts Institute of Technology ×6

Accelerator rootsportfolio companies that came through a program

Y Combinator ×18Techstars ×8500 Global ×3

89 founders hold a PhD · 66 hold an MBA (of 466 with degree data) · backed the same founder in 2+ companies: 5 founders

Investments · 1,115 tracked

founders shown can be your intro path

By year:2026 · 412025 · 462024 · 202023 · 282022 · 602021 · 342020 · 222019 · 352018 · 282017 · 222016 · 272015 · 33432 dated

Monte Rosa Therapeuticsmonterosatx.comin𝕏NASDAQ: GLUESep 2020✓ verified

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in

Board seatAli Behbahani· per SEC Form D

Co-investorsAisling CapitalVersant VenturesHBM PartnersAmzak HealthAvoro Capital AdvisorsGV (Google Ventures)+1 more

BuzzFeedbuzzfeed.com𝕏NASDAQ: BZFDSeries C · Feb 2015 · $16M

BuzzFeed is a digital media company that produces entertainment, news, and content across pop culture, food, and commerce for online audiences.

ConsumerCreator EconomyMedia & EntertainmentNew York, US

Jonah Peretti(Director and President of AI)inJohn Johnson III(Director)Mark Frackt(Executive Officer)Greg Coleman(Executive Officer, Director)Allison Lucas(Executive Officer)JON STEINBERG(President and Chief Operating Officer)in

Board seatPatrick Kerins· per SEC Form D

Co-investorsAndreessen HorowitzLerer HippeauVelvet Sea VenturesRRE Ventures

Courseracoursera.orgin𝕏NYSE: COURJul 2020

Coursera is an online learning platform offering courses, certificates, and career programs from universities and companies such as Google.

EdTechEnterprise SoftwareFuture of WorkMarketplacesSaaSMountain View, US

Daphne Koller(Co-Founder & President)inAndrew Ng(Director)inRichard Levin(Chief Executive Officer)

BoardDan Avida(Director)John Doerr(Director)in

Board seatScott Sandell· per SEC Form D

Co-investorsAllied Venture PartnersFelicis VenturesG SquaredGSV VenturesKleiner PerkinsLearn Capital+10 more

CVRxcvrx.comin𝕏NASDAQ: CVRXMay 2016

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in

Board seatAli Behbahani· per SEC Form D

Co-investorsTreo Ventures, LlcWindham Capital PartnersYsios CapitalAction Potential Venture Capital Ltd.Hatteras Venture PartnersVensana Capital

Mirum Pharmaceuticalsmirumpharma.comin𝕏NASDAQ: MIRMNov 2018

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

Chris Peetz(Co-founder & Chief Executive Officer)inEric Bjerkholt(Executive Officer)inPeter Radovich(Executive Officer)in

BoardPatrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Board seatEdward T. MathersEd Mathers· per SEC Form D

Co-investorsChiesi VenturesFrazier Life SciencesPappas CapitalRiverVest Venture PartnersDeerfield Management CompanyFrazier Healthcare Partners+2 more

NextNav HoldingsNASDAQ: NNSep 2016SEC filingmedium confidence

NextNav Holdings develops ground-based positioning, navigation, and timing systems designed to complement and back up GPS using low-band spectrum assets, serving wireless carriers, government agencies, and public safety applications including enhanced 911 services.

Mclean, US

Ganesh Pattabiraman(Executive Officer, Director)Eric Swank(Chief Financial Officer)Gary Parsons(Executive Officer, Director)Mariam Sorond(President and Chief Executive Officer and Chair of the Board of Directors)

BoardBandel Carano(Director)inMatt Skaruppa(Director)

Board seatPeter Barris· per SEC Form D · $35M raise · filed Sep 2016

Co-investorsOak Investment Partners

Nkarta, Inc.nkartatx.cominNASDAQ: NKTXAug 2019

Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.

BiotechHealthtechSouth San Francisco, US

Paul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)inPaul J. Hastings(Chief Executive Officer)in

BoardMichael Dybbs(Director)Jill Carroll(Director)in

Board seatAli Behbahani· per SEC Form D

Co-investorsRA CapitalSamsara BioCapitalSR One Capital ManagementAmgen VenturesLogosNorwest Venture Partners+1 more

Onkure Therapeutics Inconkuretherapeutics.comin𝕏NASDAQ: OKUROct 2024

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)inSamuel Agresta(Executive Officer)inDylan Hartley(Executive Officer)inWendy Johnson(Executive Officer)Nicholas A. Saccomano(President and Chief Executive Officer and Director)

BoardIsaac Manke(Director)in

Board seatEdward T. Mathers· per SEC Form D

Co-investorsAccess BiotechnologyBoulder VenturesRiverVest Venture PartnersAbingworthACORN BIOVENTURESNovo Holdings

Robinhoodrobinhood.comin𝕏NASDAQ: HOODOct 2020

Robinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets.

FintechMenlo Park, US

BAIJU BHATT(Executive Officer, Director)inVlad Tenev(Co-founder & CEO)inBaiju Bhatt(Co-founder)inJASON WARNICK(Executive Officer)inGRETCHEN HOWARD(Executive Officer)in

Board seatScott Sandell· per SEC Form D

Co-investors1/1 CapitalACME CapitalAlgerAmplo VenturesAndreessen HorowitzBLN Capital+42 more

Senti Biosciencessentibio.comin𝕏NASDAQ: SNTIFeb 2018

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)

BoardDonald Tang(Director)

Board seatEd Mathers· per SEC Form D

Co-investorsEvolution VC PartnersFlucas VenturesLifeforce CapitalLux CapitalMenlo VenturesNSG Ventures+10 more

Sprout Socialsproutsocial.comin𝕏NASDAQ: SPTDec 2018 · $40.5M

Sprout Social offers a social media management platform with AI, automation, integrations and analytics tools for marketing teams.

AI & Machine LearningMarketing TechSaaSSocialChicago, US

Aaron Rankin(Executive Officer, Director)inJustyn Howard(Executive Officer, Director)inPeter Soung(Founder)in

BoardEric Lefkofksy(Director)Jason Kreuziger(Director)

Board seatPeter Barris· per SEC Form D

Co-investorsLightbankGoldman Sachs

Spyglass Pharmaspyglasspharma.cominNASDAQ: SGPMay 2025

SpyGlass Pharma develops a sustained drug delivery platform for treating chronic ophthalmic diseases such as glaucoma, integrating drugs, procedures, and devices for long-term disease control and vision preservation.

BiotechHealthtechMedical DevicesAliso Viejo, US

Glenn Sussman(Co-founder)inMalik Y. Kahook(Co-founder)inPatrick Mooney(CEO)

BoardJake Merrill(Director)Geoff Pardo(Director)Bilal Khan(Director)

Board seatAli Behbahani· per SEC Form D

Co-investorsRA CapitalSamsara BioCapitalSands Capital VenturesVensana Capital

Synlogicsynlogictx.comin𝕏OTC: SYBXFeb 2016

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)inPaul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in

Board seatEd Mathers· per SEC Form D

Co-investorsAtlas VentureNSG VenturesPfizer Venture InvestmentsSofinnova VenturesSolasta VenturesOrbiMed

Tempustempus.comNASDAQ: TEMOct 2022

Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas.

Chicago, US

Eric Lefkofsky(Founder)inErik Phelps(Executive Officer)Ryan Fukushima(Executive Officer)in

BoardBrad Keywell(Director)

Board seatScott GottliebPeter Barris· per SEC Form D

Co-investorsCompoundFPVKhosla VenturesLightbankRevolutionTMC Venture Fund+2 more

Twiliotwilio.comin𝕏NYSE: TWLOJul 2021SEC filingmedium confidence

Twilio provides a cloud-based communications platform that enables businesses to integrate voice, messaging, and video into applications using APIs.

Cloud ComputingDeveloper ToolsEnterprise SoftwareSan Francisco, US

Jeff Lawson(Co-Founder & Chief Executive Officer)inEvan Cooke(Director)John WolthuisinLee Kirkpatrick(Chief Financial Officer)inRoy Ng(Executive Officer)inKaryn Smith(Executive Officer)in

Board seatJeff Immelt· per SEC Form D · $378.2M raise · filed Jul 2021

Co-investors500 GlobalBessemer Venture PartnersDraper AssociatesFounders Circle CapitalFounders FundIcon Ventures+16 more

Adaptimmuneadaptimmune.comin𝕏OTC: ADAPYSep 2014

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical DevicesAbingdon, Oxfordshire, US

James Noble(Chief Executive Officer)Adrian Rawcliffe(Chief Executive Officer and Director)inGavin Wood(Chief Financial Officer)inWilliam Bertrand(Chief Operating Officer)inJohn Lunger(Chief Patient Supply Officer)inElliot Norry(Chief Medical Officer)in

Co-investorsAvoro Capital AdvisorsEight Roads VenturesF-Prime CapitalForesite CapitalRidgeback Capital

Addex Therapeuticsaddextherapeutics.comin𝕏NASDAQ: ADXN

Addex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.

BiotechHealthtechGeneva

Roger Mills(Executive Officer, Director)inMikhail Kalinichev(Executive Officer)inJean-Philippe Rocher(Executive Officer)inRobert Lutjens(Executive Officer)inTimothy Dyer(Executive Officer, Director)Vincent Lawton(Director)

Co-investorsSofinnova PartnersACORN BIOVENTURESSR One Capital Management

Akari Therapeuticsakaritx.comin𝕏NASDAQ: AKTX

Akari Therapeutics is an oncology biotechnology company developing antibody drug conjugates (ADCs) built on a proprietary PH1 spliceosome-modulating payload that disrupts RNA splicing in cancer cells.

BiotechDeep TechHealthtechTampa, US

Kameel Farag(Interim Chief Financial Officer)inAbizer Gaslightwala(President and Chief Executive Officer)inGur Roshwalb(Executive Officer, Director)inClive Richardson(Executive Officer, Director)inDov Elefant(Executive Officer)Ray Prudo(Director)

Black Diamond Therapeutics, Incblackdiamondtherapeutics.comNASDAQ: BDTX

Black Diamond Therapeutics develops small-molecule kinase inhibitors targeting families of oncogenic mutations across cancer types, including its lead candidate silevertinib for EGFR-mutant lung cancer and glioblastoma.

Elizabeth Buck(Chief Scientific Officer)inBrent Hatzis-Schoch(Chief Operating Officer and General Counsel)inSergey Yurasov(Chief Medical Officer)inMelanie Morrison(Chief Development Officer)

Co-investorsLAVLilly Asia VenturesNextech InvestNSG VenturesRA CapitalVersant Ventures+3 more

Bloom Energybloomenergy.comin𝕏NYSE: BE

Bloom Energy manufactures solid oxide fuel cell systems for onsite power generation at commercial, industrial, and data center facilities.

CleantechEnergyHardware

K.R. Sridhar(Founder, Chairman, and CEO)KR Sridhar, PhD(Founder, Chairman and Chief Executive Officer)

Co-investorsArtis VenturesConstellation Technology VenturesDag VenturesEnerdigm VenturesG SquaredJC2 Ventures+7 more

Boston Scientificbostonscientific.cominNYSE: BSXAcquired

Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

HealthtechMedical Devices

John AbeleinPeter NicholasLance BatesinJonathan R. Monson(Executive Vice President and Chief Financial Officer)Miriam O'Sullivan(Senior Vice President, Chief Human Resources Officer)inMichael F. Mahoney(Chairman of the Board, President and Chief Executive Officer)

Co-investorsAndera PartnersCatalyst Health VenturesCouncilExcelestar VenturesGood Growth CapitalLongitude Capital+6 more

Celcuitycelcuity.comin𝕏NASDAQ: CELC

Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers.

BiotechHealthtechMedical DevicesMinneapolis, US

Lance G. Laing(Executive Officer, Director, Promoter)inBrian F. Sullivan(Executive Officer, Director, Promoter)inLance G. Laing, Ph.D.(Chief Science Officer, Vice President, Secretary and Director)Vicky Hahne(Executive Officer)in

BoardDavid F. Dalvey(Director)inRichard E. Buller(Director)

Co-investorsBrightstone Venture Capital

Champions Oncologychampionsoncology.comin𝕏NASDAQ: CSBR

Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.

AI & Machine LearningBiotechHealthtechHackensack, US

Ronnie Morris(Executive Officer, Director)inRonnie Morris, M.D.(Executive Officer, Director)inJames McGorry(Executive Officer)David Miller(Chief Financial Officer)inJoel Ackerman(Executive Officer, Director)inRob Brainin(Chief Executive Officer)in

Co-investorsBattery VenturesIsrael Biotech Fund

Cylanceblackberry.cominNYSE: BB

BlackBerry operates two divisions focused on security and innovation: one providing end-to-end encryption and zero-trust identity control for governments and critical industries, and another offering QNX embedded software and real-time operating systems used in over 275 million vehicles worldwide.

CybersecurityEnterprise SoftwareIoTIrvine, US

Stuart McClure(Executive Officer, Director)inJeffrey Ishmael(Executive Officer)

BoardPatrick Heim(Director)Mark Hatfield(Director)Alex Doll(Director)Alexander Weiss(Director)

Co-investorsCrosslink CapitalKhosla VenturesOmega Venture PartnersRembrandt Venture PartnersRiverwood CapitalBlumberg Capital+1 more

Datalogixoracle.comNYSE: ORCL

Oracle sells enterprise database software, applications and cloud infrastructure, and has grown through large acquisitions including PeopleSoft, Siebel and Sun Microsystems.

Austin, US

Diego Pantoja-Navajas(Executive Officer, Director)Lawrence J. Ellison(Executive Chair, Chief Technology Officer and Founder)MICHAEL CASEY(Executive Officer)ARUN MURUGAN(Executive Officer)Clayton M. Magouyrk(CEO)Michael D. Sicilia(CEO)

Co-investorsAdvancit CapitalAkkadian VenturesAlliance VCAlliance VentureBessemer Venture PartnersElevate Ventures+20 more

Duolingoduolingo.comin𝕏NASDAQ: DUOL

Duolingo offers app-based language learning through short, game-like lessons that teach reading, writing, listening, and speaking, using AI and language science to personalize the experience.

AI & Machine LearningConsumerEdTechPittsburgh, US

Severin Hacker(Director)inLuis von Ahn(Executive Officer, Director)in

BoardBrad Burnham(Director)inAndrew Moore(Director)

Co-investorsCapitalGDrive CapitalFelicis VenturesFirebolt Ventures Management Company, LlcK2 GlobalKleiner Perkins+7 more

Elasticelastic.coin𝕏NYSE: ESTC

Elastic develops search-powered software for enterprises, offering products for search, observability, and security built on Elasticsearch.

AI & Machine LearningCloud ComputingCybersecurityData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

Teunis Steven Schuurman(Director)Steven Schuurman(Co-founder, former Chief Executive Officer and current director)Uri Boness(Co-founder and former engineering/product leader)inSimon Willnauer(Co-founder and former Elasticsearch engineer)inShay Banon(Founder and CTO)inW.H. Baird Garrett(Executive Officer)

Co-investorsAmplify PartnersIndex VenturesNorwest Venture PartnersSV AngelBenchmark

Enliven Therapeuticsenliventherapeutics.cominNASDAQ: ELVN

Enliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology.

BiotechHealthtechBoulder, US

Sam Kintz(Co-founder and Head of Pipeline)inJoe Lyssikatos(Co-founder and Research Fellow)Anish Patel(Co-founder and Chief Operating Officer)Rick Fair(Chief Executive Officer and Member of the Board of Directors)inHelen Collins(Chief Medical Officer)inBen Hohl(Chief Financial Officer and Head of Corporate Development)in

Co-investors5AM VenturesOrbiMedPfizer Venture InvestmentsRoche Venture FundARCH Venture PartnersBay City Capital+1 more

Fiscal Notefiscalnote.comin𝕏OTC: NOTE

FiscalNote provides AI-powered software that aggregates and interprets legislative and regulatory data to help organizations track and influence policy outcomes.

AI & Machine LearningData & InfrastructureGovTechSaaSWashington, US

Tim Hwang(Co-founder)inGerald Yao(Co-founder)inJonathan Chen(Co-founder)inTimothy Hwang(Executive Officer, Director)Paul Donnell(Chief Accounting Officer)inJon Slabaugh(CFO and Senior VP of Corporate Development)in

Co-investors645 VenturesChaac VenturesConversion CapitalDorm RoomEastward Capital PartnersElysium Ventures+16 more

Force10dell.cominNYSE: DELL

Dell designs and sells computing hardware including laptops (XPS, Alienware gaming), monitors, webcams, and PowerEdge servers, along with IT lifecycle management and support services.

ConsumerEnterprise SoftwareHardwareRound Rock, US

Michael Dell(Founder)inMichael S. Dell(Chairman of the Board and Chief Executive Officer)in

Co-investorsIcon VenturesJackson Square VenturesPartners for GrowthPartners for Growth (PFG)Utah Governor’s Office of Economic Development (GOED)

Gerongeron.cominNASDAQ: GERN

Geron is a biopharmaceutical company focused on developing therapies for blood cancer.

BiotechHealthtechLongevityMedical Devices

Michael D. WestHarout Semerjian(President and Chief Executive Officer)inMichelle J. Robertson(Executive Vice President, Chief Financial Officer, Treasurer and Interim Secretary)inJoseph Eid(Executive Vice President, Research and Development, Chief Medical Officer)inAhmed ElNawawi(Executive Vice President, Chief Commercial Officer)in

Co-investorsBioBrit

Gossamer Biogossamerbio.comin𝕏NASDAQ: GOSS

Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib, an investigational drug candidate for treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechDigital HealthMedical DevicesSan Diego, US

Faheem Hasnain(Executive Officer, Director)inChristian Waage(Executive Officer)inSheila Gujrathi, MD(Founder)inBryan Giraudo(Executive Officer)Laura Carter, Ph.D.(Executive Officer)Robert Smith(Executive Officer)

Co-investorsARCH Venture PartnersBay City CapitalEcoR1 CapitalFoothill VenturesSamsara BioCapitalOmega Funds

Groupon, Inc.groupon.comin𝕏NASDAQ: GRPN

Groupon operates a marketplace connecting consumers with discounted deals from local and national merchants across restaurants, beauty services, travel, entertainment, and retail products.

E-commerceMarketplacesRetail Tech

Andrew Mason(Founder)inDusan Senkypl(Chief Executive Officer)inJiri Ponrt(Chief Operating Officer)inRana Kashyap(Chief Financial Officer)in

Co-investorsAccelAndreessen HorowitzBattery VenturesInterlace VenturesMaveronPale Fire Capital+4 more

ImaraNASDAQ: ELVNMar 2019 · $63Macquired by Enliven Therapeutics · Feb 2023

Imara is a clinical-stage biopharmaceutical company developing small molecule therapeutics for unmet medical needs, currently advancing ELVN-001, a selective kinase inhibitor designed to treat chronic myeloid leukemia by targeting the BCR-ABL gene fusion.

BiotechCambridge, US

James G. McArthur(Executive Officer, Director)Christoph M. Adams(Executive Officer, Director)Richard Fair(President, Chief Executive Officer, Director)

BoardSara Nayeem(Director)Barbara Dalton(Director)David Mott(Director)

Co-investorsBay City CapitalRA CapitalAlexandriaArix BioscienceLundbeckfonden VenturesOrbiMed+2 more

Iridex Corporationiridex.comin𝕏NASDAQ: IRIX

Iridex makes laser systems, EndoProbe handpieces, and vitreoretinal surgical consumables used for precision eye surgery in hospitals and ambulatory surgery centers.

HardwareHealthtechMedical DevicesMountain View, US

Patrick Mercer(Chief Executive Officer)inRomeo Dizon(Executive Officer)

BoardYu-Hao Chen(Director)Scott Shuda(Director)William Moore(Director)Beverly Huss(Director)

Co-investorsIncubic Management LLC

Korro Biokorrobio.comin𝕏NASDAQ: KRROMay 2019 · $70M

Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.

BiotechHealthtechCambridge, US

Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in

BoardJean-Francois Formela(Director)in

Co-investorsAtlas VentureMC Healthcare VenturesAlexandriaQiming Venture Partners USARock Springs CapitalTaiwania Capital+1 more

Lexicon Pharmaceuticalslexpharma.cominNASDAQ: LXRX

Lexicon Pharmaceuticals develops and commercializes pharmaceutical products, including the marketed drug INPEFA and drug candidates in clinical development such as sotagliflozin, pilavapadin, and LX9851, serving patients in need of treatments across various therapeutic areas.

BiotechThe Woodlands, US

Brian P. Zambrowicz(Executive Officer)inBrian T. Crum(Executive Officer)inRachel Martens(Executive Officer)inScott Coiante(Executive Officer)Craig B. Granowitz(Executive Officer)inWendy E. McDermott(Executive Officer)in

Liquidia Corporationliquidia.cominNASDAQ: LQDAApr 2021

Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechMorrisville, US

Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in

BoardPaul B. Manning(Director)inStephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)

Co-investorsCanaan PartnersPBM Capital

Marker Therapeuticsmarkertherapeutics.cominNASDAQ: MRKR

Marker Therapeutics develops novel T cell therapies, including adoptive T cell therapy approaches, for clinical applications in oncology and other diseases with high unmet need.

BiotechHealthtechHouston, US

Juan Vera(Executive Officer, Director)inDr. Vera(Co-founder)Glynn Wilson(Executive Officer, Director)John Bonfiglio(Executive Officer, Director)

BoardSteven Elms(Director)inJohn Wilson(Director)

Co-investorsAisling Capital

Mirna Therapeuticsblogmedicina.com𝕏OTC: SYBX

A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.

BiotechMedia & EntertainmentAustin, US

Matthew Winkler(Director)Sinil Kim(Executive Officer)inPaul Lammers(Executive Officer, Director)inJon Irvin(Executive Officer)Casi DeYoung(Executive Officer)

BoardMichael Powell(Director)

Co-investorsPfizer Venture InvestmentsOrbiMedOUP (Osage University Partners)

MongoDBmongodb.comin𝕏NASDAQ: MDBDec 2014

MongoDB is a cloud database company that provides Atlas, a multi-cloud data platform for transactional, search, and generative AI workloads, along with enterprise on-premises options and integration tools for developers and partners.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsNew York, US

Dwight Merriman(Director)inEliot Horowitz(Co-Founder & Chief Technology Officer)inChirantan 'CJ' Desai(President & CEO)Sydney Carey(Chief Financial Officer)inDev Ittycheria(Chief Executive Officer)in

BoardRoelof Botha(Director)in

Co-investorsAlleyCorpDell Technologies CapitalFlybridge Capital PartnersFoundryMaC Venture CapitalOpen Field Capital+4 more

Nektar Therapeuticsnektar.cominNASDAQ: NKTR

Nektar develops therapies that modulate the immune system to treat autoimmune diseases and inflammatory conditions, targeting the root causes of immune dysfunction.

BiotechHealthtechSan Francisco, US

Howard W. Robin(Executive Officer, Director)Gil M. Labrucherie(Executive Officer)inManinder Hora(Executive Officer)inStephen K. Doberstein(Executive Officer)John Nicholson(Executive Officer)Jillian B. Thomsen(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERS

NeuroPaceneuropace.comin𝕏NASDAQ: NPCEAug 2020

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Digital HealthHardwareHealthtechMedical DevicesMountain View, US

Rebecca Kuhn(Executive Officer)inFrank Fischer(Executive Officer, Director)Joel Becker(President, Chief Executive Officer and Director)inVince Burgess(Director)inRenee Ryan(Director)inRay Larkin(Director)

Co-investorsAccelmed PartnersOrbiMed

Nextnavnextnav.comin𝕏NASDAQ: NN

NextNav builds positioning, navigation, and timing (PNT) services using spectrum as a complement and backup to GPS, addressing vulnerabilities in indoor, urban, and critical infrastructure environments.

Deep TechDefense TechIoTSpace TechReston, US

Arun Raghupathy(Co-Founder and Chief Technology Officer)inGanesh Pattabiraman(Chief Executive Officer)MARIAM SOROND(Executive Officer, Director)inSUSAN INSLEY(Executive Officer)inJAMES BLACK(Executive Officer)inCHRISTIAN GATES(Executive Officer)in

Co-investorsColumbia CapitalOak Investment Partners

Omada Healthomadahealth.comin𝕏NASDAQ: OMDA

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)inSean Duffy(Executive Officer, Director)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)in

BoardJonathan Root(Director)in

Co-investorsaMoonAndreessen HorowitzBlackbird GiantsCanvas VenturesCivilization Ventures Management, LlcDesigner Fund+14 more

Opendooropendoor.comin𝕏NASDAQ: OPEN

Opendoor offers instant cash offers for residential properties through real estate agents, allowing sellers to choose between a fast sale or list the home later.

B2B MarketplacesE-commerceMarketplacesPropTechPhoenix, US

Eric Wu(Co-founder)inJD Ross(Cofounder)Keith Rabois(Co-founder)inKaz Nejatian(Chief Executive Officer)in

Co-investorsA*Access Technology VenturesAndreessen HorowitzBlue Lion GlobalCoatue ManagementCrunchFund+26 more

ORIC Pharmaceuticalsoricpharma.cominNASDAQ: ORIC

ORIC Pharmaceuticals is a clinical-stage oncology company developing therapies aimed at overcoming cancer treatment resistance, including innate, acquired, and bypass resistance.

BiotechHealthtechSouth San Francisco, US

Richard Heyman(Chairman, Founder, Scientific Advisory Board)inCharles Sawyers(Founder, Scientific Advisory Board)Scott Lowe(Founder, Scientific Advisory Board)Dominic Piscitelli(Chief Financial Officer)inPratik Multani(Chief Medical Officer)inJacob Chacko(President, Chief Executive Officer and Board Member)in

Co-investorsEcoR1 CapitalNextech InvestTaiho Ventures, LLCThe Column GroupOrbiMed

PagerDutypagerduty.comin𝕏NYSE: PD

PagerDuty provides a platform for incident response and operations management that enables teams across technical and business functions to respond to critical events in real time.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Alex Solomon(Founder/CTO)inDan Alexandru Solomon(Director)Jennifer Tejada(Executive Chair)inSteven Gatoff(Executive Officer)inJohn DiLullo(Chief Executive Officer)in

BoardJohn O'Farrell(Director)

Co-investorsAccelAndreessen HorowitzAurumBaseline VenturesBessemer Venture PartnersBling Capital+14 more

Sagimet Biosciencessagimet.cominNASDAQ: SGMTFeb 2019 · $18M

Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology.

BiotechDigital HealthHealthtechMenlo Park, US

Rekha Hemrajani(Executive Officer)inMerdad Parsey(Executive Officer, Director)inDavid Happel(Chief Executive Officer & Director)Andreas Grauer(Chief Medical Officer)inThierry Chauche(Chief Financial Officer)inMarie O'Farrell(Chief Scientific Officer)in

Co-investorsAltium CapitalHM Venture PartnersKleiner PerkinsBAM ElevateBiotechnology Value FundWestlake Village BioPartners

Savarasavarapharma.cominNASDAQ: SVRA

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.

BiotechHealthtechMedical DevicesAustin, US

Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)

Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkGreen Park & Golf VenturesKeiretsu ForumMoore Venture Partners

SenseonicsNASDAQ: SENS

Senseonics develops and commercializes an implantable continuous glucose monitoring system called Eversense that measures blood glucose levels for extended periods (up to 12 months) via a subcutaneous sensor and rechargeable transmitter, serving people with diabetes as an alternative to conventional CGM devices that require replacement every 1-2 weeks.

BiotechGermantown, US

Mirasol Panlilio(Executive Officer)inR. Don Elsey(Executive Officer)Mukul Jain(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Francine R. Kaufman(Chief Medical Officer)inBrian Hansen(Chief Commercial Officer)

Senseonics Holdingssenseonics.comNASDAQ: SENS

Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement.

BiotechGermantown, US

Mukul Jain(Executive Officer)Francine R. Kaufman(Executive Officer, Director)inRick Sullivan(Executive Officer)inKenneth L Horton(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Mirasol Panlilio(Executive Officer)in

Co-investorsVensana Capital

Snapsnapchat.comNYSE: SNAPApr 2014

Snapchat is a mobile app for communicating with friends and family through photos and videos, featuring augmented-reality Lenses, creative sharing tools, and a personalized map for discovering places and content.

ConsumerCreator EconomyMedia & EntertainmentSocialSanta Monica, US

Evan Spiegel(Co-founder and Chief Executive Officer)inBobby Murphy(Co-founder and Chief Technology Officer)Reggie Brown(Co-founder; former Chief Marketing Officer)Newton Porter(Executive Officer, Director)Taylor Auerbach(Executive Officer, Director)Tim Sehn(Executive Officer)

Co-investorsA-Rod CorpAccess Technology VenturesAlibaba GroupCapitalGCoatue ManagementEntrée Capital+31 more

Surf Airsurfair.comin𝕏NYSE: SRFM

Surf Air Mobility operates regional air travel across the U.S. through scheduled flights, on-demand private charter booking, and electric aviation technology.

CleantechMobility & TransportationTravel & HospitalityHawthorne, US

Sudhin Shahani(Director)inOliver Reeves(Executive Officer)Tyler Painter(Director)Deanna White(Executive Officer)inJames Bailey(Director)Bruce Gonzalez(Executive Officer)

Co-investorsBase Venture Management, Inc.Ff Venture CapitalMucker CapitalPartners for GrowthPartners for Growth (PFG)The Global Emerging Markets Group (GEM)+2 more

Trevi Therapeuticstrevitherapeutics.comin𝕏NASDAQ: TRVI

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio (oral nalbuphine ER), an investigational therapy for chronic cough that targets the central and peripheral cough reflex arc.

BiotechHealthtechNew Haven, US

Thomas Sciascia(Executive Officer)Jennifer Good(Co-Founder, President and CEO)inThomas Sciascia, M.D.(Co-Founder, Chief Scientific Officer)Lisa Delfini(Executive Officer)inWilliam Forbes(Executive Officer)inMichael Heffernan(Director)in

Co-investorsAPERTURE Venture PartnersFrazier Life SciencesOmega Funds

Tuyatuya.comin𝕏NYSE: TUYA

Tuya's LLM solution provides integrated AI services and customizable AI Copilot development tools that let businesses build, deploy, and evaluate large language models across sectors including real estate, healthcare, retail, and manufacturing.

AI & Machine LearningCloud ComputingEnterprise SoftwareHardwareIoT

Co-investorsATM CapitalQiming Venture PartnersVision Plus Capital

Uberuber.comin𝕏NYSE: UBER

Uber operates a multi-sided platform providing ride-sharing, food delivery, freight logistics, and business fleet management services across various global markets.

Logistics & Supply ChainMarketplacesMobility & TransportationSan Francisco, US

Travis Kalanick(Co-founder & CEO)Garrett Camp(Co-founder)Gautam Gupta(Executive Officer)inJeffrey Holden(Executive Officer)David Plouffe(Executive Officer)inEmil Michael(Executive Officer)in

Co-investors137 Ventures408 VenturesA*ACME CapitalAcross Capital PartnersAglae Ventures+67 more

Upwork (formerly oDesk)upwork.comNASDAQ: UPWK

Upwork operates two interconnected digital platforms that match businesses with independent contractors and agency workers: the Upwork Marketplace, a freelance work platform where clients post projects and pay service fees on transactions, and Lifted, an enterprise-focused platform for managing contingent labor across multiple engagement models including contractors, staff augmentation, and outsourcing.

Hayden Brown(Chief Executive Officer)inGiulietta Pezzaniti(Chief People Officer)

Co-investors408 VenturesDag VenturesFirstMark CapitalGarage CapitalGlobespan Capital PartnersJackson Square Ventures+6 more

VistaGen Therapeuticsvistagen.comNASDAQ: VTGN

VistaGen Therapeutics develops intranasal pherine compounds targeting neuropsychiatric and women's health conditions through a mechanism that activates nasal sensory neurons to modulate brain circuits without systemic absorption.

BiotechSouth San Francisco, US

H. Ralph Snodgrass(Executive Officer, Director)Jerrold D. Dotson(Executive Officer)Shawn K. Singh(Executive Officer, Director)inA. Franklin Rice(Vice President of Corporate Development)

BoardUnderdown J. Brian(Director)Gregory A. Bonfiglio(Director)

X4 Pharmax4pharma.comin𝕏NASDAQ: XFOR

X4 Pharmaceuticals is a biopharmaceutical company developing medicines for people living with rare immune disorders, including chronic neutropenia.

BiotechBoston, US

Mary DiBiase(Executive Officer)inChristophe Arbet-Engels(Executive Officer)inDavid Kirske(Executive Officer)inJohn Volpone(Executive Officer)inMark Baldry(Executive Officer)Adam Craig(Executive Officer, Director)in

Co-investorsBain Capital Life SciencesLumira VenturesPartners ResoluteThynk CapitalOmega FundsPolaris Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aptive SystemsArazAset TherapeuticsBranch Metrics, Inc.Bright HealthComplexaCRISPR TherapeuticsCurzion Pharmaceuticals IncCydan IIEBH HoldingFirstLight Bio, Inc.Flow CommerceGoEuroLaunchpad Therapeutics, Inc.Nexo Therapeutics, Inc.Nusantara HoldingsOne ConcernOnfido LtdRetrieve TechnologiesRocket.Chat Holdings, Ltd.SiteTrakerSnagfilmsSolace TherapeuticsStable Coin Inc.Tamara Mellon BrandTravelator

Browse all 1,115 investments with full details →

915 more tracked companies

UpskillVirgin PulseVori HealthWaltz NetworksWaymarkWizard CommerceWonder GroupX9, Inc.ZeroFox (NYSE: 2022)011BOG23andMe3Com Corporation3ware42Floors4351offerAcadia PharmaceuticalsAcclarentAciexAcquiaAcrivon TherapeuticsActions Semiconductor Co., Ltd.AddThisAdvanced CardiovascularAelurosAerohive NetworksAerospikeAffimedAffinia TherapeuticsAI FundAI SquaredAir WorksAjax Vascular, Inc.AlconAlexza PharmaceuticalsAlienVaultAlimerasciencesAllakos IncAllay TherapeuticsAlteon WebSystemsAmber TherapeuticsAmerican Pathology PartnersAmerigroup CorporationAmicus TherapeuticsAMISYS Managed CareAmplitudeAmplyx PharmaceuticalsAnacorAneuRxAnnexonAnteriorAntimatterAntimatterAntimatterAnyscaleAnywhereAnywhereAppianApplixApprendaAppriva MedicalAquabyteAquantiaArchieArdelyxArgon NetworksArkestroARRIS CompositesArrowPointAscend CommunicationsAstral PointAtheros CommunicationsAttestAudienceAugustAurelianAurinia PharmaceuticalsAvailinkAvenzoAVEO OncologyAviadoBio WebsiteBackflipBackflip AIBaihe Holding CorporationBarkly ProtectsBasalt Health The AI-powered health care assistant Visit →Bay Networks (Wellfleet Comm)BCD SemiconductorBeachMintBedRocket MediabeehiivBellyBenchPrepBerkeley NetworksBerkshire GreyBestowBethesda Research LabsBig Data FederationBixbyBlack DuckBlacktagBliqBlockBlock RenovationBlockCypher Blockchain web servicesBloomReachBlue CheetahBlue Jeans NetworkBlue OceanBluefishblueshiftBNTOBNTOBoingo WirelessBokuBonsaiBoxBoxcarBraintreeBranchBranchBrandlessBravo HealthBrenig Therapeutics, Inc.Bright Health GroupBrightkiteBroadlyBroadview Network HoldingsByteDanceCadence PharmaceuticalsCandy DigitalCanopyCanopy TaxCardioThoracic SystemsCardiovascular Imaging SystemsCardurionCardurion PharmaceuticalsCarecomCareerBuilderCarezoneCarrier Access CorporationCarticept MedicalCartivaCascadian TherapeuticsCasperCasperCasper'sCatalogCatalogCatalystbiosciencesCathay Industrial Biotech, Ltd.CausesCCP GamesCentralizeCentrexion TherapeuticsCeramicCerecor Inc.ChanneladvisorCHAOSCharmCharmCharmCHARM TherapeuticsChelsio CommunicationsCHG HealthcareChina Gtel LimitedChina Health (CITIC)ChromaCodeCirrus LogicCistaClarifaiClarifyClarVista MedicalClearMetalClearMotionClearspring TechnologiesCleave BiosciencesClementiaCleversafeClioClockwork SystemsCloudflare TurnstileCLVSCodaCode BiotherapeuticsCode42CoEditionCogenesysCollectiveHealth Health falseCom21ComancheComanche BiopharmaCompass LabsComprehensive Pharmacy ServicesConceptusContraConvivaCorcaCorcaCorvisCorxelCotopaxiCourtyardCourtyard.ioCowboy Space CorporationCrewLABCRISPRCrowdboticsCrowdMedCTI BiopharmaCuralateCurana HealthCurisiumCV IngenuityCV TherapeuticsCyberMediaCyenceCyras SystemsDallas SemiconductorDandelion EnergyData DomainDatabentoDatabricksDatriumDaVita NephrolifeDecruDeltaStreamDermiraDesire2LearnDesktop MetalDevices for Vascular InterventionDiamond TherapeuticsDiatideDidiDivvyDivvyDjustDocentDOTS Technology CorpDroboDropDropDropDSI RenalDura PharmaceuticalsE*OfferingE2O CommunicationsEargoEarlenseBenXEcho Global LogisticsEchodyneEchopass CorporationECI Acquisition HoldingseConvergentEdelman Financial EnginesEdmodoEko HealthElement3 HealthEleven LabsElionEmbraceEmbraneEnceladusEnceladus BioEndocardial SolutionsEndotexEngine YardEnginesENSISEnzytechEpix TherapeuticseRoomErytech Pharma S.AESP PharmaEsprit PharmaEucalyptus SystemsEuclid AnalyticsEvalveEvenlyEventUpEveractiveEverFiEvernoteEvernowEversideEverside HealthExent TechnologiesExpanseExpelExploraMedFabFitFunFactoryFactoryFanhattanFanhouseFastinoFCG Logo.jfifFenris GamesFibexFieldglassFiftyThreeFightCampFinancial Software & SystemsFineground NetworksFintech GrowthFIRE1FirebaseFirst CryFisker AutomotiveFizzFlowFlowFlowFlowFlowFlowFlow48FollozeForerunnerForesightForethought Technologies, Inc.ForterFox Hollow TechnologiesFramebridgeFreoFriskaiFTXFTX TradingFTX USFugueFulcrum MicrosystemsFunctional FinanceFusion I/OFyusionGaikaiGainspeedGalera TherapeuticsGeistMGeltex PharmaceuticalsGen.GGenetic Therapy Inc.GeniesGenmoGeoTel CorporationGilt GroupeGlacierGlacierGladlyGladlyGlamsquadGlobal Savings GroupGlobalLogicGloucester PharmaceuticalsGLU MobileGlycomimeticsGoji SolutionsGolden AnalyticsGolden State Medical SupplyGoodGuideGoodLeapGoodyGoopGraftGrand JunctionGraphite SystemsGravelGreat JonesGreenlightGrey RhinoGreycroftgreytHRGridPointGrowth NetworksGrubwithusGuardentGuidelineGuideSparkGumGumGynecareH2CorporationHabitat HealthHackeroneHealthcare North America Growth StageHealthsouthHeapHearsayHeavyHemoSenseHiredHireguideHorizon TherapeuticshosHouse RxHowlHydra BiosciencesHYGEIA Medical Services GroupHyperfairHyperion TherapeuticsIC3 designIdfyIfOnlyIFTTTIgneousIgneous Systemsillusive networksiManageImmunex CorporationIn-House HealthIncareyIndioInfinity PharmaceuticalsInfluitive CorporationInfoGear TechnologyInfoworksInhibitexInkittInnerWorkingsInozyme PharmaInSoftIntact VascularIntact VascularIntelligenceNODEIntellisysIntrinsicInventivaInversagoIomai CorporationIOpipeISGN Technologies Ltd.Jomboy MediaJuniper NetworksJuvoJyveKaazingKaizenKaizen LabsKeelvarKetraKhoros(formerly Lithium Technologies)KindredKiraKiraKisweKnotchKongKONUXKoudaiKumuKumu NetworksLanditLanditLatitudeLatitudeLattice EnginesLaurel NetworksLayerLearnUpLedgeLedgyLegato MedicalLemonadeLeonaBioLetgoLianLianLife TechnologiesLily AILimitlessLinekong International Co., Ltd.LithiumLittle LabsLiveLoopLiza HealthLizzy AiLogikcullLong Term Care GroupLooptLoreLoxo OncologyLumenaLuminalLuminary MicroLuminate WirelessLumos PharmaLungpacer MedicalLXAMagenta MedicalMainstream DataMaintainXMapD TechnologiesMarathon HealthMarketoMartianMartian AI / 2023MashginMaster ClassMatroidMayhem SecurityMBX BiosciencesMediaoceanMediSys EduTechMEI Pharmamejuri storyMergeMergeMerlinMersanaMetabaseMetacrineMetaventionMetromileMetronomemi|imMicro FocusMighty AIMillennial MediaMimosa Networks IncMindeeMindTickleMinimumMission Critical SoftwareMissMaliniMobiSocialMobius Management SystemsModa OperandiModyfiMojo VisionMoonpayMore HealthMotion ComputingMotricityMotus TherapeuticsMovius Interactive CorporationMuleSoftMyFitMyogenNaaptolNaked LabsNamespaceNationwide Remittance CentersNEA PortfolioNefeli NetworksNellcorNeo CyberneticaNeoterisNeoTractNetSolveNeueHealthNeural MagicNeuralieveNeutral TandemNevroNEW WAVENew Wave FoodsNewGlobenewScaleNexchemNexImmuneNext Power 360NG.CASHNginxNiaraNiciraNightstarNimble CollectiveNimble StorageNinjaOneNitraNodeNoonlightNordsenseNova FertilityNovaceptNovast Holdings LimitedNovatiumNth RoundNuelleNuvoloOANDAObsEvaOmioOmthera Pharmaceuticalsonelobbylogo-01OnshapeOnStreamOrbis MedicinesOrby AIOrexigen TherapeuticsOrigin MedsystemsOrphoMedOuro MedicinesOzonePacketeerPagerPair EyewearPalo Alto NetworksPanacea Medical TechnologiesParc PlacePatientKeeperPatreonPcOrderPegasystemsPentahoPeplinPerplexityPersonal Genome DiagnosticsPharmionPhaseBio PharmaceuticalsPhathom PharmaceuticalsPhiloPhysical IntelligencePicabooPILOT AI LABS, INC.Pinnacle EnginesPionyr ImmunotherapeuticsPixieBrixPlacemeterPlaidPlatoPlay Versus Inc.PlaydomPlayers TribunePlayVSPluribus NetworksPlusmoPocketPolyservePopaiPoppy Handcrafted PopcornPortAuthorityppoNEXTPredictive BiosciencesPrime Financial TechnologiesProcketProgress SoftwareProof of LearnProofoflearnProsensaProteostasis TherapeuticsProxima TherapeuticsPsyadon PharmaceuticalsPulsePure EnergiesPyxisQpex BiopharmaQualifiedQuantum Bridge CommunicationsQuidsi (Diapers.com)QuoteWellRa PharmaceuticalsRaiseRapid RoboticsRavelReachifyRead the Press ReleaseRecludixRedbabyRefresh ClubRegression Games list viewRegulus Therapeutics Inc.Relay VenturesRelievant MedsystemsReltioReneoReneo PharmaceuticalsResilienceRetrieveRevelioRevelle AestheticsRevSpringRewindRF MonolithicsRf SurgicalRigel PharmaceuticalsRingCubeRock HealthRocketRocketRuntimeRx RedefinedSafeBaseSafeRide HealthSakana AISalixSamaya AISan Francisco, CASana LabsSaphoSasken CommunicationsSavara PharmaceuticalsSaveSAY MediaSBCSCI SolutionsScopely, Inc.Scout RFPScoutibleScratch Music GroupSemiconductor Manufacturing International Corporation (SMIC)SengledSentonsSentrySepracorSerious EnergySierra AtlanticSilicon Blue TechnologiesSilicon SpiceSimple HabitSimple PsychologySimpleRoseSimplex HealthcareSimsolidSingularitySisuSisu DataSitetrackerSiTimeSiTime Corporation (米国)SlashSlopeSlopeSmartDrive Systems, Inc.SnowplowSocialRadarSolar JunctionSolidFireSolta MedicalSome Spider StudiosSomerville, MASonatypeSonic InnovationsSoraSoraaSourcefireSourcery.AISpare5SpectrianSpektrSpinewaveSpirationSplice BioSpoknSpreadtrum CommunicationsSpringpathSproutStablixStarCityStashStemcentrxStormpathStreamsetStride HealthStrive HealthStrongbridge BiopharmaSubtextSugarAISugarCRMSun EdisonSunDeckSuperSuperAppSuperGenSupernus PharmaceuticalsSupplyBaseSurface OncologySurgical HealthSurgRxSwift NavigationSwiftypeSwirldsSwitchOn NetworksSyllableTableauTableau SoftwareTabulaTabulaTagkastTagworks PharmaceuticalsTailorTamaramellonTamrTarveda TherapeuticsTeal DronesTechnical CommunitiesTele AtlasTelebit CorpTelegent SystemsTempest TherapeuticsTenerosTeracentTestMartThankfulThe Climate CorporationThe FoundryThe Players TribuneThe WellThe WingThe WingThe YesTheorycraft GamesTherachonThirdLoveThumbnail for Escient PharmaceuticalsThumbnail for Seragon PharmaceuticalsThunkableTiburio TherapeuticsTidal TherapeuticsTidemarkTiger Data (creators of TimescaleDB)TigeraTintriTivoTogether AITokenzToolingToperaTopiaTrackMavenTRACON PharmaceuticalsTractTrading DynamicsTranscept PharmaceuticalsTransfixTransifexTranslucentTranslucent AITransvascularTravelbankTrevenaTrillium TherapeuticsTripodtriValenceTrivascularTuriTwelveTwenty (YC S23)U First CapitalU S Renal CareUhanaUlinkUltheraUltraDNSUnbound SecurityUnifyIDUnionUpskillUpworthyUrsaUUNETValleysteerValueFirstVantage OncologyVAST DataVenmoVerona PharmaVertex PharmaceuticalsVerticaVertiFlexVeza Technologies Inc.ViddyVideologyVimaan RoboticsViracta Therapeutics (formerly Sunesis)VirataVirtelaVirtruVishwaVitesse SemiconductorVividCortexVixs SystemsVocalocityVtesseVuclipVytronUSWallapopWaymarkWebEx CommunicationsWebMD (Healtheon)WheelhouseWheelhouseWheels UpWiiTHWillowWillowWireWheelWispr FlowWizardWNP CommunicationsWoebotWoebot HealthWorkdayWorkeraWorld LabsXaira TherapeuticsXcelXfireXoc PharmaceuticalsXoom CorporationXrosXskyXtuitYardYubicoYuga Labs (BAYC)ZaniaZeroZhone TechnologiesZiarcoZingtreeZoomdataZosanoZumperZuoyebang株式会社プレイド

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 139

65 IPOs · 74 acquisitions · showing 64

Monte Rosa TherapeuticsNASDAQ: GLUEBuzzFeedNASDAQ: BZFDCourseraNYSE: COURCVRxNASDAQ: CVRXMirum PharmaceuticalsNASDAQ: MIRMNextNav HoldingsNASDAQ: NNNkarta, Inc.NASDAQ: NKTXOnkure Therapeutics IncNASDAQ: OKURRobinhoodNASDAQ: HOODSenti BiosciencesNASDAQ: SNTISprout SocialNASDAQ: SPTSpyglass PharmaNASDAQ: SGPSynlogicOTC: SYBXTempusNASDAQ: TEMTwilioNYSE: TWLOAdaptimmuneOTC: ADAPYAddex TherapeuticsNASDAQ: ADXNAkari TherapeuticsNASDAQ: AKTXBlack Diamond Therapeutics, IncNASDAQ: BDTXBloom EnergyNYSE: BEBoston ScientificNYSE: BSXCelcuityNASDAQ: CELCChampions OncologyNASDAQ: CSBRCylanceNYSE: BBDatalogixNYSE: ORCLDuolingoNASDAQ: DUOLElasticNYSE: ESTCEnliven TherapeuticsNASDAQ: ELVNFiscal NoteOTC: NOTEForce10NYSE: DELLGeronNASDAQ: GERNGossamer BioNASDAQ: GOSSGroupon, Inc.NASDAQ: GRPNImaraNASDAQ: ELVNIridex CorporationNASDAQ: IRIXKorro BioNASDAQ: KRROLexicon PharmaceuticalsNASDAQ: LXRXLiquidia CorporationNASDAQ: LQDAMarker TherapeuticsNASDAQ: MRKRMirna TherapeuticsOTC: SYBXMongoDBNASDAQ: MDBNektar TherapeuticsNASDAQ: NKTRNeuroPaceNASDAQ: NPCENextnavNASDAQ: NNOmada HealthNASDAQ: OMDAOpendoorNASDAQ: OPENORIC PharmaceuticalsNASDAQ: ORICPagerDutyNYSE: PDSagimet BiosciencesNASDAQ: SGMTSavaraNASDAQ: SVRASenseonicsNASDAQ: SENSSenseonics HoldingsNASDAQ: SENSSnapNYSE: SNAPSurf AirNYSE: SRFMTrevi TherapeuticsNASDAQ: TRVITuyaNYSE: TUYAUberNYSE: UBERUpwork (formerly oDesk)NASDAQ: UPWKVistaGen TherapeuticsNASDAQ: VTGNX4 PharmaNASDAQ: XFORXenon PharmaNASDAQ: XENEZenas BiopharmaNASDAQ: ZBIOCatalyticacq. by PagerDutyCurzion Pharmaceuticals Incacq. by Horizon Therapeutics

Portfolio news

latest coverage across their companies

Fund performance · per public LP disclosures · 19

as of Sep 2025
FundVintageCommittedNet IRRTVPIDPI
NEA SH 2025 SPVLPs: Orange County Employees Retirement System20251.00x
NEA 18 VentureLPs: Los Angeles City Employees' Retirement System20221.8%1.03x0.00x
NEA 18 Venture Growth EquityLPs: California State Teachers' Retirement System, Los Angeles City Employees' Retirement System, Orange County Employees Retirement System202211.6%1.20x
New Enterprise Associates 18LPs: Nebraska Investment Council, Los Angeles City Employees' Retirement System, California State Teachers' Retirement System +2 more202240.5%1.86x0.11x
New Enterprise Associates 18rLPs: Orange County Employees Retirement System202241.0%2.00x0.11x
New Enterprise Associates 17LPs: California State Teachers' Retirement System, Nebraska Investment Council, Los Angeles City Employees' Retirement System +2 more20194.5%1.17x0.16x
New Enterprise Associates 16LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +1 more20178.2%1.52x0.42x
NEA 15 Opportunity Fund, L.P.LPs: North Carolina Retirement Systems, California State Teachers' Retirement System201525.2%3.68x1.44x
NEA 15, L.P.LPs: North Carolina Retirement Systems201511.3%1.83x1.03x
New Enterprise Associates 15LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +2 more201510.0%1.75x1.05x
NEA 14, L.P.LPs: North Carolina Retirement Systems201214.9%2.71x1.14x
New Enterprise Associates 13LPs: California State Teachers' Retirement System, Nebraska Investment Council, New Mexico Public Employees Retirement Association +3 more20082.76x2.57x
New Enterprise Associates 12, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +3 more20066.4%1.40x1.39x
New Enterprise Associates 11LPs: California State Teachers' Retirement System, Pennsylvania Public School Employees' Retirement System, Hawaii Employees' Retirement System200415.3%2.65x2.57x
New Enterprises Associates VIII A, L.P.LPs: California State Teachers' Retirement System2001-2.4%0.79x0.79x
New Enterprise Associates 10, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +2 more20002.3%1.20x1.13x
New Enterprise Associates 9, L.P.LPs: California State Teachers' Retirement System, Hawaii Employees' Retirement System, John S. and James L. Knight Foundation1999-6.1%0.46x0.46x
New Enterprises Associates VIII, L.P.LPs: California State Teachers' Retirement System199830.6%1.66x1.64x
NEW ENTERPRISE ASSOCIATES 14, L.P.LPs: California State Teachers' Retirement System, New Mexico Public Employees Retirement Association, Hawaii Employees' Retirement System +3 more3.31x1.50x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

IPO stake values · per SEC filings · 14

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Sprout Social14.2%$27.50Aug 2020$166.3M
Monte Rosa Therapeutics15.0%$19.00Jun 2021$126.4M
Spyglass Pharma20.2%$16.00Feb 2026$103.3M
Mirum Pharmaceuticals16.5%$20.00Jan 2020$83.7M
Senseonics Holdings27.4%$2.85Mar 2016$73M
Senseonics27.4%$2.85Mar 2016$73M
Onkure Therapeutics Inc17.0%$15.00Apr 2021$61.8M
Imara21.4%$16.00Mar 2020$56.7M
Enliven Therapeutics21.4%$16.00Mar 2020$56.7M
Black Diamond Therapeutics, Inc7.7%$19.00Jan 2020$50.3M
Trevi Therapeutics27.7%$10.00May 2019$49.3M
Zenas Biopharma3.6%$17.00Sep 2024$24.5M
Synlogic14.8%$7.00Oct 2015$20.8M
Champions Oncology20.9%$2.25Jun 2016$5.4M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has New Enterprise Associates (NEA) made?
New Enterprise Associates (NEA) has 1,115 tracked investments, 139 of which have exited, including 89 dated in the last 24 months.
What stage does New Enterprise Associates (NEA) invest at?
New Enterprise Associates (NEA) invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is New Enterprise Associates (NEA)'s typical check size?
New Enterprise Associates (NEA) typically writes checks of $200K – $40M.
What sectors does New Enterprise Associates (NEA) focus on?
New Enterprise Associates (NEA) focuses on AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Sector Agnostic.
Where is New Enterprise Associates (NEA) located?
New Enterprise Associates (NEA) is headquartered in Menlo Park, US.
Does New Enterprise Associates (NEA) lead rounds?
Yes, New Enterprise Associates (NEA) leads investment rounds.
Who does New Enterprise Associates (NEA) co-invest with?
New Enterprise Associates (NEA) most often shares deals with Andreessen Horowitz, NewView Capital, Norwest Venture Partners, among 1,313 tracked co-investors.

Media · Podcasts & interviews

featuring the team

250th 1Mby1M Entrepreneurship Podcast With Scott Sandell, NEA - 1Mby1M Entrepreneurship Podcast

1Mby1M Roundtables · Scott Sandell

NEA's Scott Sandell May Have The Most IPOs Of All Time. Here's How He Did It | Ep. 10 I/O Podcast

IO Podcast · Scott Sandell

Keynote Fireside Chat with Scott Sandell - Chairman, CEO & Chief Investment Officer, NEA

MIT Initiative on the Digital Economy · Scott Sandell

Helping to Build a Better Internet - (Cloudflare) Matthew Prince & (NEA) Scott Sandell | Slush 2022

Slush · Scott Sandell

Back to the Future: Building Impactful Companies - Scott Sandell (NEA) | Slush 2022

Slush · Scott Sandell

Scott Sandell | How to last for 100 years in venture capital

Slush · Scott Sandell

Images

New Enterprise Associates (NEA) photo

Co-investors · 399

NewView Capital

NewView Capital is a venture capital firm that provides flexible capital to growth-stage companies, investing on a primary, secondary, or hybrid basis and offering operational guidance on scale-up decisions.

Menlo Ventures

Menlo Ventures is a venture capital firm that invests in transformative, early-stage AI companies across every layer of the modern AI stack, from applications and middleware to data infrastructure and foundation models.

$1M – $20M
Lightspeed Venture Partners

Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.

$1.7M – $87M
Index Ventures

Index Ventures is a multi-stage venture capital firm that backs companies from Seed to IPO and beyond, including through its dedicated seed fund Index Origin.

$540K – $10.8M
GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M
Insight Partners

Insight Partners is an investment firm focused on accelerating revenue and profit growth in software companies, providing capital and operational support through its Insight Onsite team.

$120M – $350M
387 more co-investors

GreycroftSoftBank Vision FundBessemer Venture PartnersFelicis VenturesSV AngelIVP (Institutional Venture Partners)Battery VenturesLux CapitalNotable CapitalOrbiMedGreylock PartnersTechstars8VCAisling CapitalLightstone VenturesGeneral CatalystCoatue ManagementF-Prime CapitalVersant VenturesEvolution VC PartnersMadrona Venture GroupIntel CapitalComcast VenturesRA CapitalSofinnova VenturesForesite CapitalTiger Global ManagementCapitalGPfizer Venture InvestmentsBenchmarkCanaan PartnersSapphire VenturesRuna CapitalRedpoint VenturesUnion Square Ventures (USV)Storm VenturesRiverVest Venture PartnersFounders FundFoundation CapitalCisco InvestmentsFlare Capital PartnersSR One Capital ManagementSanofi VenturesVensana CapitalGradient VenturesRRE VenturesOak HC/FTMeritech Capital PartnersLerer HippeauWingTenaya CapitalQualcomm VenturesOwl VenturesAbingworthAlumni VenturesFirst Round CapitalBoxGroupSignalFireCanvas VenturesGeneral AtlanticThird Point VenturesArtis VenturesFrazier Healthcare PartnersNextech InvestFounder CollectiveBain Capital VenturesGreat Oaks Venture CapitalStreamlined VenturesBonfire VenturesVenrockGoodwater CapitalMatrixSpeedinvest137 VenturesRadical VenturesOUP (Osage University Partners)MVP VenturesAscension VenturesTuesday CapitalBalderton CapitalSusa VenturesSlow VenturesForerunner VenturesEmergence Capital PartnersCota CapitalAcrew CapitalAtlas VentureSherpalo VenturesWinklevoss CapitalAlleyCorpAugust CapitalARCH Venture PartnersCrosscut VenturesBasis Set VenturesConstruct CapitalAI Fund5AM VenturesDeerfield Management CompanyEnergize CapitalGreen Bay VenturesTensility Venture PartnersPappas CapitalClarus VenturesQuadrille CapitalCraft VenturesSpark CapitalACME CapitalInnovation EndeavorsObvious VenturesMaveronNorthzoneAIX VenturesDreamers VCBallistic VenturesMaC Venture CapitalHOF CapitalMulticoin CapitalLearn CapitalvenBio PartnersThe Column GroupGranite AsiaMorgenthalerRethink Capital PartnersYsios CapitalRoche Venture FundTriplePoint CapitalRed & Blue VenturesLong Journey VenturesB Capital GroupCRV (Charles River Ventures)Eniac VenturesFirstMark CapitalBling CapitalAccel-KKRAdditionPICUS CAPITALBond Capital ManagementSoma CapitalRibbit CapitalRidge VenturesThrive CapitalPear VCKortschak Investments L.P.Cowboy VenturesHV CapitalDraper Fisher Jurvetson (DFJ)Pelion Venture PartnersSpider CapitalJavelin Venture PartnersBreakthrough Energy VenturesFELIX CAPITALCollaborative FundEndeavor CatalystGE VenturesH.I.G. Growth PartnersAlpaca VCMiramar Venture PartnersGSV VenturesOmega FundsVelvet Sea VenturesDST GlobalAME Cloud VenturesSciFi VCKapor CapitalFlybridge Capital PartnersBowery CapitalSierra Ventures01 AdvisorsParadigmSocial LeverageDCM VenturesEQT VenturesGaingelsChemistryThe Chernin Group (TCG Crypto)Standard CapitalNext Play VenturesLeft Lane CapitalWebb Investment NetworkEnergy Impact PartnersValar Ventures LlcCoelius CapitalFf Venture CapitalGiant Ventures Global LlpWalden InternationalMMC Ventures9Yards CapitalFuture Perfect VenturesSilverton PartnersEnsemble VCPitangoRace CapitalAmity VenturesJAZZ Venture PartnersTMVEQT Life SciencesNorthpond VenturesDimension CapitalJump CapitalIlluminate VenturesModerne VenturesForbionXplorer CapitalCervinDomain AssociatesSparkLabs Global VenturesLiveOak VenturesCavalry VenturesNovartis Venture FundImaginary Venture CapitalHarpoon VenturesCVS Health VenturesJDRF T1D FundCosmic Venture PartnersUberEverywhere VenturesTrue VenturesQuiet CapitalSOSVLiquid VenturesIA VenturesTrinity VenturesHarrison MetalAccompliceGlobal Founders CapitalShasta VenturesCostanoa VenturesEclipse Ventures23andMeICONIQ CapitalViola VenturesLakestarTransmedia CapitalDecibel PartnersOMERS VenturesMosaic VenturesPrefix CapitalPreston-Werner VenturesFormation GroupTeam8White Star CapitalScrum VenturesAlvenStageOne VenturesBlueRun VenturesHelium-3 VenturesJetstreamGreenoaksAmasiaFusionVoyager CapitalHighbury HoldingsAmplo VenturesRoot Ventures Manager, LlcSutter Hill VenturesPaladin Capital GroupPrelude VenturesNeotribe VenturesWestCapCultivation CapitalArriveAV8 VenturesAtlantic Bridge VenturesCerity Partners VenturesredalpineTola CapitalElaiaSlack FundMizMaa Ventures7wire VenturesListen VenturesArboretum VenturesOCA VenturesRoosh VenturesBig Idea VenturesArthur VenturesMax VenturesArbor VenturesCore Innovation CapitalOptum VenturesCelonisMorpheus VenturesInkefAnsa CapitalVida VenturesNTT Venture CapitalCore Venture CapitalMercury Fund17SigmaAgent CapitalBCF Ventures4BIO CapitalGeekdomLam CapitalHBM PartnersSante VenturesSamsung VenturesSancus VenturesAble PartnersUncork CapitalUnknown VenturesKrakenGoat CapitalOffline VenturesNextView VenturesHCVCFreestyle CapitalStellar CapitalAfore CapitalStride VCTrajectory VenturesHack VCNot Boring CapitalHanabi CapitalQueensBridge Venture PartnersTq Ventures LlcSalesforce Japan Co.,Ltd.WGI GroupMS&AD VenturesBetaworks Ventures Management, LlcDigital Currency GroupHyde Park Venture PartnersCompany Capital2xNPolychain CapitalAmerican Express Ventures (Amex)The Finger GroupKohlberg Kravis RobertsAllison Pickens VenturesUnpopular Venturesxfactor venturesLa FamigliaK2 GlobalUP PartnersPresight CapitalSignia Venture PartnersActive CapitalThink+ Ventures Management, LlcNext Coast VenturesEuclid Venture PartnersWestWave CapitalPrimitive VenturesBINARY CAPITALFYRFLY Venture PartnersMoonfire VenturesGutbrain VenturesBootstrapLabsS CapitalWalden Catalystf7 VenturesBuilders VCLigature VCMysten LabsRedpoint eventuresMetamorphic VenturesPrime Movers LabBain Capital VenturePatronMarathon Venture CapitalStanford UniversityZintinusAmara VCEnergy Capital VenturesMakers CampElephant PartnersMaverick CapitalLeadout CapitalMatter Venture PartnersStarVest PartnershumbitionChainforestAmerica's Frontier FundCollide CapitalOkapi Venture CapitalOpenCapital.vcUpheaval InvestmentsWealthing VC ClubPlaneteer CapitalTuring CapitalVoyager PartnersFlorida FundersMohr Davidow VenturesOutliers VC82VSEmmeline VenturesNest.Bio VenturesSingle Fin Ventures

Firms observed investing alongside New Enterprise Associates (NEA), from public investor directories. Shared companies are the overlap with New Enterprise Associates (NEA)'s recorded portfolio.

Similar investors

Featured in lists